BR0008703A - Utilização da tianeptina para a obtenção de medicamentos destinados ao tratamento das patologias da neurodegenerescência - Google Patents

Utilização da tianeptina para a obtenção de medicamentos destinados ao tratamento das patologias da neurodegenerescência

Info

Publication number
BR0008703A
BR0008703A BR0008703-3A BR0008703A BR0008703A BR 0008703 A BR0008703 A BR 0008703A BR 0008703 A BR0008703 A BR 0008703A BR 0008703 A BR0008703 A BR 0008703A
Authority
BR
Brazil
Prior art keywords
treatment
tianeptine
neurodegeneration disorders
obtain medicines
neurodegeneration
Prior art date
Application number
BR0008703-3A
Other languages
English (en)
Inventor
Antoine Deslandes
Michael Spedding
Original Assignee
Adir
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adir filed Critical Adir
Publication of BR0008703A publication Critical patent/BR0008703A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/554—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one sulfur as ring hetero atoms, e.g. clothiapine, diltiazem
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Psychiatry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pain & Pain Management (AREA)
  • Psychology (AREA)
  • AIDS & HIV (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Nutrition Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Patente de Invenção: "UTILIZAçãO DA TIANEPTINA PARA A OBTENçãO DE MEDICAMENTOS DESTINADOS AO TRATAMENTO DAS PATOLOGIAS DA NEURODEGENERESCêNCIA". A invenção refere-se à utilização da Tianeptina ou de seus enantiómeros para a obtenção de medicamentos úteis no tratamento das patologias da neurodegenerescência.
BR0008703-3A 1999-04-07 2000-04-06 Utilização da tianeptina para a obtenção de medicamentos destinados ao tratamento das patologias da neurodegenerescência BR0008703A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9904313A FR2791891A1 (fr) 1999-04-07 1999-04-07 Utilisation de la tianeptine pour l'obtention de medicaments destines au traitement des pathologies de la neurodegenerescence
PCT/FR2000/000865 WO2000059511A1 (fr) 1999-04-07 2000-04-06 Utilisation de la tianeptine pour l'obtention de medicaments destines au traitement des pathologies de la neurodegenerescence

Publications (1)

Publication Number Publication Date
BR0008703A true BR0008703A (pt) 2002-02-13

Family

ID=9544103

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0008703-3A BR0008703A (pt) 1999-04-07 2000-04-06 Utilização da tianeptina para a obtenção de medicamentos destinados ao tratamento das patologias da neurodegenerescência

Country Status (17)

Country Link
US (1) US6599896B1 (pt)
EP (1) EP1165089A1 (pt)
JP (1) JP2002541110A (pt)
KR (1) KR20010102463A (pt)
CN (1) CN1342082A (pt)
AU (1) AU3824800A (pt)
BR (1) BR0008703A (pt)
CA (1) CA2361988A1 (pt)
EA (1) EA200100802A1 (pt)
FR (1) FR2791891A1 (pt)
HK (1) HK1042053A1 (pt)
HU (1) HUP0200145A3 (pt)
NO (1) NO20014081L (pt)
NZ (1) NZ513565A (pt)
PL (1) PL356739A1 (pt)
WO (1) WO2000059511A1 (pt)
ZA (1) ZA200106690B (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030045449A1 (en) * 2001-08-15 2003-03-06 Pfizer, Inc. Pharmaceutical combinations for the treatment of neurodegenerative diseases
CA2562078A1 (en) * 2004-04-08 2005-10-27 Vela Pharmaceuticals, Inc. Compositions and methods for treatment of neuropathic pain, fibromyalgia and chronic fatigue syndrome
EP1752143A1 (en) * 2005-08-08 2007-02-14 NewThera Novel uses for drugs targeting glutamine synthetase
US9314469B2 (en) * 2008-05-05 2016-04-19 Tonix Pharma Holdings Limited Method for treating neurocognitive dysfunction
US8198268B2 (en) * 2008-10-31 2012-06-12 Janssen Biotech, Inc. Tianeptine sulfate salt forms and methods of making and using the same
JO2844B1 (en) * 2008-10-31 2014-09-15 ترانسفورم فارماسيتيكالز، انك.‏ Forms of Tyapentin sulfate salt and methods of its manufacture and use
KR20120092993A (ko) * 2011-02-14 2012-08-22 지엘팜텍 주식회사 티아넵틴 또는 이의 약제학적으로 허용되는 염을 포함하는 경구투여용 서방성 정제
KR101136976B1 (ko) * 2011-09-06 2012-05-30 건일제약 주식회사 티아넵틴 또는 그의 염을 포함하는 탈모증의 예방 또는 치료용 약학 조성물
AU2017385958B2 (en) 2016-12-28 2021-12-02 Tonix Pharma Holdings Limited Tianeptine oxalate salts and polymorphs

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2635461B1 (fr) * 1988-08-18 1992-01-17 Adir Utilisation de derives tricycliques pour l'obtention de medicaments destines au traitement du stress
FR2716623B1 (fr) * 1994-02-25 1996-08-23 Adir Utilisation d'un dérivé tricyclique pour l'obtention de médicaments destinés au traitement des troubles mnémo-cognitifs.
FR2747921B1 (fr) * 1996-04-24 1998-10-30 Adir Comprime matriciel permettant la liberation prolongee du sel de sodium de tianeptine apres administration par voie orale

Also Published As

Publication number Publication date
EP1165089A1 (fr) 2002-01-02
HUP0200145A2 (hu) 2002-05-29
PL356739A1 (en) 2004-06-28
CA2361988A1 (fr) 2000-10-12
WO2000059511A1 (fr) 2000-10-12
FR2791891A1 (fr) 2000-10-13
NO20014081D0 (no) 2001-08-22
NO20014081L (no) 2001-08-22
EA200100802A1 (ru) 2002-04-25
AU3824800A (en) 2000-10-23
HK1042053A1 (zh) 2002-08-02
US6599896B1 (en) 2003-07-29
JP2002541110A (ja) 2002-12-03
HUP0200145A3 (en) 2004-07-28
NZ513565A (en) 2004-04-30
ZA200106690B (en) 2002-11-14
CN1342082A (zh) 2002-03-27
KR20010102463A (ko) 2001-11-15

Similar Documents

Publication Publication Date Title
MY127980A (en) A pyrrolidineacetamide derivative alone or in combination for treatment of cns disorders
HUP0103856A3 (en) Pharmaceutical composition for the treatment of acute disorders
PT1181027E (pt) Composicao dietetica ou farmaceutica para utilizacao na prevencao ou tratamento de hiperoxaluria
HUP9700603A3 (en) Pharmaceutical preparation for the treatment of blood coagulation disorders
AU9287401A (en) Benzopyrancarboxylic acid derivatives for the treatment of diabetes and lipid disorders
HUP0003381A3 (en) Use of topiramate or derivatives thereof for the manufacture of a medicament for the treatment of manic-depressive bipolar disorders
MY135838A (en) Methods for the treatment of mental disorders
NO20005884L (no) Kombinasjonsterapi for behandling av bipolare forstyrrelser
PL346904A1 (en) Pharmaceutical agents for the treatment of parkinson's disease, adhd and microadenomas
BR0008703A (pt) Utilização da tianeptina para a obtenção de medicamentos destinados ao tratamento das patologias da neurodegenerescência
IS6137A (is) Meðhöndlun á hugsýkistruflunum
BR9707210A (pt) Preparado de combinação farmacêutico a partir de análogos de ihrh e antiestrogênios para o tratamento de distúrbios ginecológicos
NO20012106L (no) Middel for behandling av forstyrrelser i benmetabolismen
TR200000455T2 (tr) Alzheimer hastalığının tedavisinde fankinonun kullanılması.
EE200100689A (et) IL6RIL6 kimääri kasutamine ravimi valmistamiseks,mis on ette nähtud neuroloogiliste haiguste ravimiseks, ning farmatseutiline kompositsioon
AU2002226060A1 (en) Compositions containing gangliosides for use in the treatment of skin disorders
CA2260863A1 (en) Treatment of psychotic disorders
EE200100527A (et) Osanetandi kasutamine meeleoluhäirete raviks kasulike ravimite valmistamiseks
BR0214060A (pt) Uso de monoidroxicarbamazepina em distúrbio afetivo e de atenção e dor neuropática
FR2774289B1 (fr) Medicament pour le traitement des dereglements de l'apoptose
BR9801839A (pt) Medicamento analgésico e aplicação de (+) -0-demetiltramadol.
ID28817A (id) Penggunaan turunan-turunan tetrahidropiridin (atau4-hidropiperidin)-butilazol dalam pembuatan obat untuk perawatan nyeri
PT1235573E (pt) Associacao de riluzole e de gabapentina e sua utilizacao como medicamento no tratamento das doencas motoneuronais
BR9714184A (pt) Utilização de bonzoillquil-1,2,3,6-tetraidropiridinas
AUPP195398A0 (en) Pharmaceutical or veterinary composition for the treatment of skin disorders

Legal Events

Date Code Title Description
PC Transfer

Free format text: LES LABORATOIRES SERVIER (FR)

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 6A, 7A E 8A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO PUBLICADO NA RPI 1962 DE 12/08/2008.